Mental Health DailyResearch. Evidence. Perspective.Published research on treatment resistant depression.
Provigil (Modafinil) is a eugeroic drug that was originally approved in 1998 for the treatment of excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obst…
Read articleA new antidepressant chemically named “GLYX-13” was developed by the biotech company Naurex for individuals with treatment-resistant depression. It is currently in clinical trials as an anti…
Read articleALKS-5461 is a new drug that is being developed by the company Alkermes as an alternative to SSRI’s for the treatment of depression. ALKS-5461 (its trial name) is a combination of both bupre…
Read articleAs technology advances, it is hoped that newer, more effective treatments for mental illness are developed. One newer treatment option that has been tested is that of Low-Field Magnetic Stim…
Read articleI’m not sure when pharmaceutical companies started marketing that a “chemical imbalance” is the cause of depression. Either way, this is a great marketing ploy that really gets people to bel…
Read articleAntidepressant augmentation strategies are commonly reviewed when an individual is unresponsive to monotherapeutic treatment. In other words, people that try treatments by themselves such as…
Read articleSuboxone (Buprenorphine) is a medication that is used by people withdrawing from narcotics (opioids). It helps alleviate withdrawal symptoms and most people end up able to experience a smoot…
Read article